Cornerstone Planning Group LLC Acadia Pharmaceuticals Inc Put Options Transaction History
Cornerstone Planning Group LLC
- $322 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ACAD
# of Institutions
304Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$804 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$259 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$249 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$219 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$113 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.03B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...